Oddity Tech Ltd. ODD
20.37 USD -1.20 (-5.56%)
At closeNov 5, 2026, 4:42 PM EST
20.37 0.00 0.00%
After hours · Nov 5, 4:42 PM ET
20.28 Day range 21.80
9.25 52-week range 46.45
- YTD
- -49.30%
- 1 year
- -51.84%
News
zacks.com New Strong Buy Stocks for November 4th DBI, EQNR, BNED, LNG and ODD have been added to the Zacks Rank #1 (Strong Buy) List on November 4, 2026.
zacks.com New Strong Buy Stocks for October 29th ODD, BOOM, BSRR, AIN and MUR have been added to the Zacks Rank #1 (Strong Buy) List on October 29th, 2026.
globenewswire.com ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026 NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced that it will release its third quarter 2026 financial results before the market open on Wednesday, November…
gurufocus.com Baillie Gifford Trims ODDITY Tech Ltd (ODD) Stake -- Shares Look 55% Undervalued on GF Value A Small Trim Within a Long-Term Framework Baillie Gifford (Trades, Portfolio) reduced its position in ODDITY Tech Ltd (ODD) on 2026-09-30, selling 398,467 share
gurufocus.com Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027 Mountain View, CA, Oct 23, 2026 - (JCN Newswire) - Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (Nasdaq: UNCY), a clinical-stage biotechnology co
gurufocus.com ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026 ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology and Phase 2 Clinical Pipelines at BIO-Europe 2026PR NewswireSEOUL, South Ko
gurufocus.com Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027 - Resubmission includes Chemistry, Manufacturing, and Controls (CMC) data from new drug product (DP) manufacturing vendorMountain View, CA, Oct 22, 2026 - (ACN
zacks.com Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know Oddity Tech (ODD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zacks.com New Strong Buy Stocks for October 15th KMX, ACIC, ONC, ODD and WES have been added to the Zacks Rank #1 (Strong Buy) List on October 15, 2026.
globenewswire.com Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition NANJING, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company's…
gurufocus.com ODDITY Tech Ltd (ODD) Shares Fall 5.1% -- What GF Score of 71 Tells Investors On September 23, 2026, ODDITY Tech Ltd (ODD) shares fell 5.1% to $17.83, reflecting a significant drop in price performance over the last year, with a 52-week r
zacks.com Earnings Estimates Moving Higher for Oddity Tech (ODD): Time to Buy? Oddity Tech (ODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
seekingalpha.com Oddity Tech: Turnaround Potential And Discounted Debt Value Lever ODD's turnaround could benefit from improving acquisition costs, even if profitability takes longer to recover than revenue. SpoiledChild is a nice, growing revenue base. And METHODIQ and Labs offer…
benzinga.com Morgan Stanley Maintains Equal-Weight on ODDITY Tech, Raises Price Target to $16.5 Morgan Stanley analyst Dara Mohsenian maintains ODDITY Tech (NASDAQ:ODD) with a Equal-Weight and raises the price target from $10 to $16.5.
benzinga.com Truist Securities Maintains Hold on ODDITY Tech, Raises Price Target to $18 Truist Securities analyst Youssef Squali maintains ODDITY Tech (NASDAQ:ODD) with a Hold and raises the price target from $16 to $18.
benzinga.com Evercore ISI Group Maintains In-Line on ODDITY Tech, Raises Price Target to $21 Evercore ISI Group analyst Mark Mahaney maintains ODDITY Tech (NASDAQ:ODD) with a In-Line and raises the price target from $15 to $21.
fool.com Why Oddity Tech's Stock Skyrocketed 26.5% Today Oddity Tech's second-quarter sales fell 25% to $181 million, just ahead of Wall Street's target. Earnings fell from $0.92 per share to $0.20, topping analyst estimates by a penny.- benzinga.com Jefferies Maintains Hold on ODDITY Tech, Raises Price Target to $18 Jefferies analyst Brian Tanquilut maintains ODDITY Tech (NASDAQ:ODD) with a Hold and raises the price target from $16 to $18.
benzinga.com Short Squeeze And Earnings: Why ODDITY Tech Stock Spiked Wednesday ODDITY Tech (ODD) surges on strong Q3 guidance and Q2 earnings beat. Read key highlights on revenue, buybacks, and short interest.
benzinga.com Crude Oil Jumps Over 3%; Core & Main Posts Upbeat Q2 Earnings U.S. stocks fell Wednesday as energy rose and discretionary slumped; Signet and Opus surged, while ServiceTitan plunged. Oil jumped 3.6%.
seekingalpha.com Oddity Tech Ltd. (ODD) Q2 2026 Earnings Call Transcript Oddity Tech Ltd. (ODD) Q2 2026 Earnings Call Transcript
proactiveinvestors.com ODDITY shares surge on Q2 beat and raised FY26 guidance ODDITY (NASDAQ:ODD) shares jumped 14% on Thursday after the company posted second-quarter results that topped Wall Street estimates and issued a stronger-than-expected full-year profit outlook. The…
marketbeat.com ODDITY Tech Q2 Earnings Call Highlights ODDITY Tech NASDAQ: ODD reported second-quarter 2026 net revenue of $181 million, down 25% from a year earlier, as its IL MAKIAGE brand continued to face higher customer-acquisition costs tied to an…
benzinga.com Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday U.S. stocks fell, but Caleres surged 14% on strong results and higher guidance. Opus Genetics, Signet and Oddity also posted big gains.
zacks.com Oddity Tech (ODD) Beats Q2 Earnings and Revenue Estimates Oddity Tech (ODD) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.92 per share a year ago.
benzinga.com ODDITY Tech Q2 2026 Earnings Call Transcript ODDITY Tech (NASDAQ:ODD) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call…- benzinga.com Market-Moving News for September 9th TTAN: -20% | ServiceTitan shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance with its midpoint below estimates. CASY: -10% | Casey's General Stores…
benzinga.com ODDITY Tech Q2 Adj. EPS $0.20 Beats $0.16 Estimate, Sales $180.517M Beat $177.602M Estimate ODDITY Tech (NASDAQ:ODD) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.16 by 25 percent. This is a 78.26 percent decrease over earnings of $0.92 per…
globenewswire.com ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter Second quarter net revenue of $181 million, down approximately 25% year-over-year Second quarter adjusted EBITDA of $13 million Second quarter net income of $13 million and second quarter adjusted…
benzinga.com Oddity Tech Q2 Earnings Preview: Expect CPA Pressure With Early Inflection Signs Oddity Tech shares fall ahead of Q2 results. Needham analyst expects CPA pressure but signs of stabilization.
defenseworld.net Critical Comparison: ODDITY Tech (NASDAQ:ODD) versus Jamieson Wellness (OTCMKTS:JWLLF) Jamieson Wellness (OTCMKTS:JWLLF - Get Free Report) and ODDITY Tech (NASDAQ: ODD - Get Free Report) are both consumer staples companies, but which is the superior stock? We will contrast the two…
benzinga.com Truist Securities Maintains Hold on ODDITY Tech, Raises Price Target to $16 Truist Securities analyst Youssef Squali maintains ODDITY Tech (NASDAQ:ODD) with a Hold and raises the price target from $12 to $16.
benzinga.com ODDITY Tech To Repurchase $50M Of 0% Exchangeable Senior Notes Due 2030 For $35M On June 11, 2026, Oddity Finance LLC ("Oddity Finance"), a wholly-owned indirect subsidiary of ODDITY Tech Ltd. (the "Company"), entered into separate, privately negotiated repurchase agreements with…- benzinga.com Evercore ISI Group Maintains In-Line on ODDITY Tech, Lowers Price Target to $15 Evercore ISI Group analyst Mark Mahaney maintains ODDITY Tech (NASDAQ:ODD) with a In-Line and lowers the price target from $23 to $15.
benzinga.com Morgan Stanley Maintains Equal-Weight on ODDITY Tech, Lowers Price Target to $10 Morgan Stanley analyst Dara Mohsenian maintains ODDITY Tech (NASDAQ:ODD) with a Equal-Weight and lowers the price target from $16 to $10.- benzinga.com Goldman Sachs Downgrades ODDITY Tech to Sell, Lowers Price Target to $8 Goldman Sachs analyst Bonnie Herzog downgrades ODDITY Tech (NASDAQ:ODD) from Neutral to Sell and lowers the price target from $16 to $8.
- benzinga.com Barclays Maintains Underweight on ODDITY Tech, Lowers Price Target to $8 Barclays analyst Lauren Lieberman maintains ODDITY Tech (NASDAQ:ODD) with a Underweight and lowers the price target from $13 to $8.
- benzinga.com Truist Securities Maintains Hold on ODDITY Tech, Lowers Price Target to $12 Truist Securities analyst Youssef Squali maintains ODDITY Tech (NASDAQ:ODD) with a Hold and lowers the price target from $18 to $12.
benzinga.com Transcript: ODDITY Tech Q1 2026 Earnings Conference Call - benzinga.com ODDITY Tech Q1 Adj. EPS $(0.17) Misses $0.01 Estimate, Sales $197.940M Beat $187.940M Estimate ODDITY Tech (NASDAQ:ODD) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $0.01 by 1800 percent. This is a 124.64 percent decrease over earnings of $0.69…
benzinga.com Nasdaq Gains Over 1%; TJX Posts Upbeat Earnings 
benzinga.com Dow Jumps 200 Points; Lowe's Issues Weak Earnings Outlook 
benzinga.com Earnings Scheduled For February 25, 2026 
benzinga.com Top 3 Risk Off Stocks That could Lead To Your Biggest Gains This Quarter 
benzinga.com Benzinga Bulls And Bears: Nvidia, Webull, Netflix — And Tech Stocks Face Worst Sell-Off Since April Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
benzinga.com Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For November 19, 2025
benzinga.com 5 Tech Stocks Climbing Benzinga's Value Rankings Tracking upward trends in value rankings can help investors uncover opportunities before they gain broader attention. Over the past week, Benzinga's system highlighted five technology stocks showing…
benzinga.com This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - benzinga.com Earnings Scheduled For August 4, 2025